Literature DB >> 7678744

Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus.

M L Olsen1, F C Arnett, J D Reveille.   

Abstract

OBJECTIVE: To find evidence of a potential genetic predisposition to the anti-Sm or anti-RNP precipitin autoantibody responses.
METHODS: HLA-DR and DQ alleles determined by restriction fragment length polymorphism and/or oligotyping in 49 subjects with either anti-Sm alone or anti-RNP alone were compared with those in 139 race-matched normal control subjects and 59 race-matched lupus patients without anti-Sm and anti-RNP autoantibodies.
RESULTS: Black patients with anti-Sm precipitin had increased frequencies of HLA-DR2 and the DQw6-associated DQA1*0102 (P = 0.007, odds ratio [OR] = 6.7) and DQB1*0602 (P = 0.001, OR = 9.1) chain alleles compared with normal black control subjects. Black patients with anti-RNP precipitin showed significant increases in the DQw5-associated DQA1*0101 (P = 0.03, OR = 5.5) and DQB1*0501 (P = 0.002, OR = 23.3) chain alleles compared with lupus patients without anti-Sm or RNP. While patients with anti-RNP precipitin showed an increased frequency of the DQw8-associated allele DQB1*0302 (P = 0.02, OR = 3.7) compared with normal controls, as well as an increased frequency of the DQw5-associated alleles DQA1*0101 and DQB1*0501 (P = 0.05, OR = 4.2) compared with lupus patients without anti-Sm or RNP. There were no specific HLA-DR2 or DR4 subtype associations found with either anti-Sm or RNP precipitin autoantibodies.
CONCLUSION: There are distinct patterns of major histocompatibility complex class II allele associations with the anti-Sm versus the anti-RNP precipitin autoantibody responses, and HLA-DQ associations may be more primary than HLA-DR associations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678744     DOI: 10.1002/art.1780360117

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

1.  HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis.

Authors:  Binh Nguyen; Maureen D Mayes; Frank C Arnett; Deborah del Junco; John D Reveille; Emilio B Gonzalez; Hilda T Draeger; Marilyn Perry; Amir Hendiani; Kiran K Anand; Shervin Assassi
Journal:  Arthritis Rheum       Date:  2011-02

2.  Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.

Authors:  Roozbeh Sharif; Marvin J Fritzler; Maureen D Mayes; Emilio B Gonzalez; Terry A McNearney; Hilda Draeger; Murray Baron; Daniel E Furst; Dinesh K Khanna; Deborah J del Junco; Jerry A Molitor; Elena Schiopu; Kristine Phillips; James R Seibold; Richard M Silver; Robert W Simms; Marilyn Perry; Carlos Rojo; Julio Charles; Xiaodong Zhou; Sandeep K Agarwal; John D Reveille; Shervin Assassi; Frank C Arnett
Journal:  J Rheumatol       Date:  2011-05-15       Impact factor: 4.666

3.  A Child's HLA-DRB1 genotype increases maternal risk of systemic lupus erythematosus.

Authors:  Giovanna I Cruz; Xiaorong Shao; Hong Quach; Kimberly A Ho; Kirsten Sterba; Janelle A Noble; Nikolaos A Patsopoulos; Michael P Busch; Darrell J Triulzi; Wendy S W Wong; Benjamin D Solomon; John E Niederhuber; Lindsey A Criswell; Lisa F Barcellos
Journal:  J Autoimmun       Date:  2016-07-04       Impact factor: 7.094

4.  T cell reactivity against the SmD1(83-119) C terminal peptide in patients with systemic lupus erythematosus.

Authors:  G Riemekasten; C Weiss; S Schneider; A Thiel; A Bruns; F Schumann; S Bläss; G-R Burmester; F Hiepe
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

5.  HLA class II genes and antibodies against recombinant U1-nRNP proteins in patients with systemic lupus erythematosus. SLE Study Group.

Authors:  Z Yao; H P Seelig; H Ehrfeld; M Renz; K Hartung; H Deicher; E Keller; C Nevinny-Stickel; E D Albert
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

6.  Significance of extractable nuclear antigens in childhood autoimmune liver disease.

Authors:  G V Gregorio; E T Davies; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

7.  Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort.

Authors:  Heidi Jacobe; Chul Ahn; Frank C Arnett; John D Reveille
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

Review 8.  The clinical relevance of autoantibodies in scleroderma.

Authors:  Khanh T Ho; John D Reveille
Journal:  Arthritis Res Ther       Date:  2003-02-12       Impact factor: 5.156

9.  HLA-DRB1*04 as a Risk Allele to Systemic Lupus Erythematosus and Lupus Nephritis in the Malay Population of Malaysia.

Authors:  Malarvili Selvaraja; Voon Kin Chin; Maha Abdullah; Masita Arip; Syafinaz Amin-Nordin
Journal:  Front Med (Lausanne)       Date:  2021-02-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.